Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Non-Current Debt: 2015-2019

Historic Non-Current Debt for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $50,285.

  • Outlook Therapeutics' Non-Current Debt rose 766.94% to $544,924 in Q2 2020 from the same period last year, while for Jun 2020 it was $544,924, marking a year-over-year increase of 766.94%. This contributed to the annual value of $50,285 for FY2019, which is 48.94% down from last year.
  • Per Outlook Therapeutics' latest filing, its Non-Current Debt stood at $50,285 for FY2019, which was down 48.94% from $98,487 recorded in FY2018.
  • Outlook Therapeutics' 5-year Non-Current Debt high stood at $13.2 million for FY2017, and its period low was $50,285 during FY2019.
  • In the last 3 years, Outlook Therapeutics' Non-Current Debt had a median value of $98,487 in 2018 and averaged $4.5 million.
  • Per our database at Business Quant, Outlook Therapeutics' Non-Current Debt skyrocketed by 492.34% in 2017 and then crashed by 99.26% in 2018.
  • Over the past 5 years, Outlook Therapeutics' Non-Current Debt (Yearly) stood at $2.9 million in 2015, then fell by 23.57% to $2.2 million in 2016, then soared by 492.34% to $13.2 million in 2017, then plummeted by 99.26% to $98,487 in 2018, then slumped by 48.94% to $50,285 in 2019.